SEC Form 4 · accession 0001209191-17-000857
AtriCure, Inc. · ATRC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
M. Andrew Wade
Officer — SVP and CFO
Period of report
Dec 30, 2016
Accepted (ET)
Jan 4, 2017 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001323885
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 30, 2016 | A | 668 | $12.27 | A | 142,147 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended December 30, 2016.
- F2Closing price on December 30, 2016 was $19.57.